The earnings call highlighted several positive developments, such as successful enrichment of Ytterbium-176, growth in Pet Labs, and strong cash reserves. However, these were tempered by operational challenges, regulatory delays, and a high short interest in the stock, creating a balanced outlook.

Company Guidance -

Q4 2024

During the call, ASP Isotopes discussed its fiscal year 2024 results and provided insights into its operations and future projects. The company reported $4.2 million in revenue for the year, with stable performance in its PET Labs division. ASP Isotopes anticipates increased production from new manufacturing plants, including those for Carbon-14, Silicon-28, and Ytterbium-176, though specific revenue guidance for 2025 was not provided. The company mentioned a take-or-pay contract for Carbon-14 with a minimum annual revenue of $2.5 million and indicated potential sales of Ytterbium-176 at $20,000 per gram. Additionally, ASP Isotopes is focused on expanding its operations globally, with plans to build several isotope enrichment facilities and collaborate with partners in regions like South Africa and potentially North America. The company also discussed overcoming operational challenges, such as equipment malfunctions, and emphasized its commitment to achieving free cash flow positivity by the year's second half.

Successful Enrichment of Ytterbium-176

The company successfully enriched Ytterbium-176, marking a significant milestone. They have started enriching for commercial samples, indicating progress in their technological capabilities.

Pet Labs Revenue and Growth

Pet Labs reported $4 million in revenue last year and is expected to grow nicely this year due to heavy investment in the business.

Expansion Plans and New Facilities

The company plans to construct Nickel-64, Gadolinium-160, and Lithium-6 plants. They anticipate the first plant coming into action later this year, depending on government permits.

Strong Cash Position

The company ended the year with a strong cash position, enough to cover four years of free cash flow operating expenses.

Increased Headcount

The company's headcount increased from 130 to 150, with plans to selectively add more staff in key areas.

ASP Isotopes, Inc. (ASPI) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

ASPI Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Press Release	Slides	Play Transcript
Mar 31, 2025	2024 (Q4)	-0.12 / -0.12	-0.156	23.08% (+0.04)		―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

ASPI Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Mar 31, 2025	$4.18	$4.69	+12.20%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does ASP Isotopes, Inc. (ASPI) report earnings?

Currently, no data Available

What is ASP Isotopes, Inc. (ASPI) earnings time?

Currently, no data Available

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is ASPI EPS forecast?

Currently, no data Available

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing